Four Canadian Provinces Add Erelzi to Their Public Plans to Treat Inflammatory Diseases, Including Juvenile Arthritis
News Manitoba, Saskatchewan, Alberta and Newfoundland are the most recent Canadian provinces to add Sandoz’s biosimilar Erelzi (etanercept) to their provincial medication plans for the treatment of several inflammatory diseases, ... Read more